Holen Sie sich die Stockscreener-App
6.135
2.42%
0.145
Handel nachbörslich:
6.14
0.005
+0.08%
Schlusskurs vom Vortag:
$5.99
Offen:
$5.96
24-Stunden-Volumen:
82,752
Relative Volume:
0.38
Marktkapitalisierung:
$220.59M
Einnahmen:
$135.28M
Nettoeinkommen (Verlust:
$-99.56M
KGV:
-1.8479
EPS:
-3.32
Netto-Cashflow:
$-38.92M
1W Leistung:
+7.07%
1M Leistung:
+14.03%
6M Leistung:
-3.99%
1J Leistung:
-15.15%
1-Tages-Spanne:
$5.944
$6.16
1-Wochen-Bereich:
$5.56
$6.16
52-Wochen-Spanne:
$3.6793
$8.90
Lifecore Biomedical Inc Stock (LFCR) Company Profile
Firmenname
Lifecore Biomedical Inc
Sektor
Telefon
(952) 368-4300
Adresse
3515 LYMAN BOULEVARD, CHASKA
Lifecore Biomedical Inc Stock (LFCR) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2023-03-20 | Herabstufung | Stephens | Overweight → Equal-Weight |
Lifecore Biomedical Inc Aktie (LFCR) Neueste Nachrichten
Lifecore Biomedical Appoints Thomas Guldager as Vice President, Operations - GlobeNewswire
Lifecore Biomedical Makes Leadership Appointments - Contract Pharma
How To Trade (LFCR) - Stock Traders Daily
Palvella Therapeutics Appoints Matthew E. Korenberg as Chief Financial Officer - Benzinga
Hyaluronic Acid (HA) Raw Material Market Size And Forecast -Salix Pharmaceuticals, ALLERGAN, Lifecore Biomedical, LLC, S – IndiaPolitics.com - IndiaPolitics.com
Johnson Fistel LLP Investigates Lifecore Biomedical, Inc’s - GlobeNewswire
Q3 2025 Earnings Forecast for Lifecore Biomedical, Inc. Issued By Barrington Research (NASDAQ:LFCR) - MarketBeat
Brokers Set Expectations for Lifecore Biomedical, Inc.'s Q1 2026 Earnings (NASDAQ:LFCR) - MarketBeat
Wynnefield entities buy $1.2m of Lifecore Biomedical stock By Investing.com - Investing.com South Africa
Legion Partners Asset Management, LLC Increases Stake in Lifecore Biomedical Inc - GuruFocus.com
Wynnefield Partners Small Cap Acquires 122,930 Shares of Lifecore Biomedical, Inc. (NASDAQ:LFCR) Stock - MarketBeat
Wynnefield entities buy $1.2m of Lifecore Biomedical stock - Investing.com
Lifecore Biomedical stock price target increased on growth prospects By Investing.com - Investing.com UK
Lifecore Biomedical, Inc. (NASDAQ:LFCR) Q1 2025 Earnings Call Transcript - Insider Monkey
Earnings call: Lifecore Biomedical reports fiscal Q1 2025 results By Investing.com - Investing.com Australia
Earnings call: Lifecore Biomedical reports fiscal Q1 2025 results - Investing.com India
Lifecore Biomedical Inc (LFCR) Q1 2025 Earnings Call Transcript Highlights: Navigating ... By GuruFocus - Investing.com Canada
Q1 2025 Lifecore Biomedical Inc Earnings Call Transcript - Stockxpo
Lifecore Biomedical, Inc. (NASDAQ:LFCR) Shares Purchased by Marshall Wace LLP - MarketBeat
exhibit991-lfcrq1fy25ear.htm - SEC.gov
Lifecore Biomedical: Fiscal Q1 Earnings Snapshot - mySA
Lifecore Biomedical completes $24.3M private stock sale - Investing.com
Lifecore Biomedical completes $24.3M private stock sale By Investing.com - Investing.com Australia
Lifecore Raises Millions in Common Stock - Baystreet.ca
Lifecore Biomedical Raises $24.3M, Expands Capacity and Clientele - TipRanks
Lifecore Biomedical Reports First Quarter of Fiscal 2025 Financial Results and Provides Corporate Update - GlobeNewswire
Lifecore Biomedical, Inc. Reports Earnings Results for the First Quarter Ended August 25, 2024 - Marketscreener.com
Lifecore Biomedical Raises $24.3 Million in Private Placement of Common Stock - The Manila Times
Lifecore Biomedical to Report Financial Results for First Quarter of Fiscal 2025 Prior to Market Open on October 4, 2024 - The Manila Times
Lifecore secures $5M deal with Lindy Biosciences for CDMO services By Investing.com - Investing.com South Africa
Lifecore secures $5M deal with Lindy Biosciences for CDMO services - Investing.com Australia
Lindy Biosciences, Lifecore Biomedical Enter Multi-Million Dollar Development Agreement - Contract Pharma
Lifecore Biomedical Selected by Lindy Biosciences to Support Process Development and Commercial Scale-Up for - EIN News
Lifecore Biomedical Selected by Lindy Biosciences to Support Process Development and Commercial Scale-Up for Innovative Microglassification Formulation Technology - GlobeNewswire
FINAL DEADLINE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Lifecore - AccessWire
LFCR Investors Have Opportunity to Lead Lifecore Biomedical, Inc. Securities Fraud Lawsuit with the Schall Law Firm - Business Wire
LFCR DEADLINE TOMORROW: ROSEN, SKILLED INVESTOR COUNSEL, - GlobeNewswire
The Law Offices of Frank R. Cruz Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Lifecore Biomedical, Inc. (LFCR) - Business Wire
Finanzdaten der Lifecore Biomedical Inc-Aktie (LFCR)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.88%
0.42%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Kapitalisierung:
|
Volumen (24h):